286 related articles for article (PubMed ID: 21810658)
1. Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation.
Poli D; Antonucci E; Testa S; Tosetto A; Ageno W; Palareti G;
Circulation; 2011 Aug; 124(7):824-9. PubMed ID: 21810658
[TBL] [Abstract][Full Text] [Related]
2. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
Poli D; Antonucci E; Zanazzi M; Grifoni E; Testa S; Ageno W; Palareti G
Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
[TBL] [Abstract][Full Text] [Related]
3. Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
Poli D; Antonucci E; Testa S; Ageno W; Palareti G;
Thromb Res; 2013 Jan; 131(1):12-6. PubMed ID: 23141847
[TBL] [Abstract][Full Text] [Related]
4. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
Tincani E; Baldini P; Crowther MA; Zanasi A; Ferrari P; Cenci AM; Rioli G
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):47-51. PubMed ID: 20523164
[TBL] [Abstract][Full Text] [Related]
5. Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study.
Pengo V; Legnani C; Noventa F; Palareti G;
Thromb Haemost; 2001 Mar; 85(3):418-22. PubMed ID: 11307807
[TBL] [Abstract][Full Text] [Related]
6. Risk of falls and major bleeds in patients on oral anticoagulation therapy.
Donzé J; Clair C; Hug B; Rodondi N; Waeber G; Cornuz J; Aujesky D
Am J Med; 2012 Aug; 125(8):773-8. PubMed ID: 22840664
[TBL] [Abstract][Full Text] [Related]
7. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
J Am Coll Cardiol; 2009 Sep; 54(11):999-1002. PubMed ID: 19729116
[TBL] [Abstract][Full Text] [Related]
8. Risks of oral anticoagulant therapy with increasing age.
Torn M; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
Arch Intern Med; 2005 Jul; 165(13):1527-32. PubMed ID: 16009869
[TBL] [Abstract][Full Text] [Related]
9. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
10. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a 'real world' nationwide cohort study.
Olesen JB; Lip GY; Lindhardsen J; Lane DA; Ahlehoff O; Hansen ML; Raunsø J; Tolstrup JS; Hansen PR; Gislason GH; Torp-Pedersen C
Thromb Haemost; 2011 Oct; 106(4):739-49. PubMed ID: 21789337
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
12. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
13. Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.
DiMarco JP; Flaker G; Waldo AL; Corley SD; Greene HL; Safford RE; Rosenfeld LE; Mitrani G; Nemeth M;
Am Heart J; 2005 Apr; 149(4):650-6. PubMed ID: 15990748
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
Abdelhafiz AH; Wheeldon NM
Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243
[TBL] [Abstract][Full Text] [Related]
15. Assessing the risk of bleeding in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation project.
Lip GY; Banerjee A; Lagrenade I; Lane DA; Taillandier S; Fauchier L
Circ Arrhythm Electrophysiol; 2012 Oct; 5(5):941-8. PubMed ID: 22923275
[TBL] [Abstract][Full Text] [Related]
16. Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort.
Pereira de Sousa L; Burba I; Ruperto C; Lattuada L; Barbone F; Di Chiara A
J Cardiovasc Med (Hagerstown); 2013 Jul; 14(7):534-40. PubMed ID: 23328227
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of hemorrhagic complications of oral anticoagulant therapy in patients with atrial fibrillation in the daily practice of an anticoagulation clinic.
Poli D; Antonucci E; Lombardi A; Cecchi E; Corsini I; Gensini GF; Abbate R; Prisco D
Ital Heart J; 2003 Jan; 4(1):44-7. PubMed ID: 12690920
[TBL] [Abstract][Full Text] [Related]
18. Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 May; 101(5):938-42. PubMed ID: 19404548
[TBL] [Abstract][Full Text] [Related]
19. Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion.
Poli D; Antonucci E; Grifoni E; Paoletti O; Rancan E; Dentali F; Testa S
Thromb Res; 2012 May; 129(5):588-90. PubMed ID: 21975030
[TBL] [Abstract][Full Text] [Related]
20. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation.
Gallego P; Roldan V; Marín F; Romera M; Valdés M; Vicente V; Lip GY
Thromb Haemost; 2013 Dec; 110(6):1189-98. PubMed ID: 24096615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
